EVONILE · Novartis India Limited · Financials
Market Cap
37.54B INR
Shares
24.69M
Volume · Nov 13
47.36K
Avg daily vol (3M)
106.57K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
3.54B
-0.5%
FY2026
Net Income
931.8M
-7.7%
FY2026
Operating Cash Flow
467.29M
-37.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 3.36B | 3.54B | 3.56B |
| INR | 52.1M | 19.5M | 21.9M |
| INR | 59.4M | 12.6M | 7.7M |
| INR | 19M | 1.3B | 1.3B |
| INR | 58.9M | 364.8M | 295.2M |
| INR | -39.9M | 931.8M | 1.01B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 1.23B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.